Business
Rolvedon (Hanmi Pharm) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Opportunities in the rolvedon market include rising demand for patient-friendly oncology drugs, focus on improving treatment adherence, and growing investments in biologics. Expansion of outpatient cancer care and increased cancer prevalence enhance market growth. Asia-Pacific leads in growth potential, while tariffs influence costs.Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Rolvedon Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to Research
About this update from Hanmi Pharmaceutical Co., Ltd.
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"Opportunities in the rolvedon market include rising demand for patient-friendly oncology drugs, focus on improving treatment adherence, and growing investments in biologics. Expansion of outpatient cancer care and increased cancer prevalence enhance market growth. Asia-Pacific leads in growth potential, while tariffs influence costs.","length":335,"tagName":"p"},{"type":"text","content":"Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "Rolvedon Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.","length":210,"tagName":"p"},{"type":"text","content":"The historic growth of the Rolvedon market has been driven by increased chemotherapy use, rising cases of treatment-induced neutropenia, acceptance of colony-stimulating factors, expansion of oncology treatment centers, and established supportive care guidelines.","length":263,"tagName":"p"},{"type":"text","content":"Future growth is anticipated to stem from the rising demand for patient-friendly oncology drugs, enhanced treatment adherence, expansion of outpatient cancer care, investments in long-acting biologics, and the development of differentiated G-CSF formulations. Key trends include the adoption of long-acting G-CSF therapies, infection risk reduction during chemotherapy, a preference for reduced dosing frequency, and enhanced monitoring of neutrophil recovery.","length":460,"tagName":"p"},{"type":"text","content":"The rising incidence of cancer is expected to propel the Rolvedon market forward. Cancer prevalence is increasing due to aging populations, lifestyle choices, environmental factors, genetic predisposition, and better diagnostic methods. Rolvedon aids cancer patients by boosting white blood cell production and increasing neutrophil counts to minimize infection ris...